Structures by: Engel E.
Total: 7
Nevirapine-glutaric acid 1:1 co-crystal
C15H14N4O,C5H8O4
CrystEngComm (2012) 14, 7 2541
a=7.363(4)Å b=12.292(6)Å c=12.305(6)Å
α=118.571(8)° β=90.144(9)° γ=98.023(8)°
Nevirapine-maleic acid 1:1 co-crystal
C15H14N4O,C4H4O4
CrystEngComm (2012) 14, 7 2541
a=7.4001(5)Å b=10.4599(7)Å c=23.2561(16)Å
α=90.00° β=98.9680(10)° γ=90.00°
Nevirapine-rac-tartaric acid 1:1 co-crystal
C15H14N4O,C4H6O6
CrystEngComm (2012) 14, 7 2541
a=9.877(2)Å b=19.286(4)Å c=9.6971(19)Å
α=90.00° β=90.66(3)° γ=90.00°
Nevirapine-saccharin 2:1 cocrystal
2(C15H14N4O),C7H5NO3S
CrystEngComm (2012) 14, 7 2541
a=9.5649(5)Å b=13.8069(7)Å c=13.8726(7)Å
α=64.090(3)° β=79.292(2)° γ=82.686(2)°
Nevirapine-salicylic acid 2:1 co-crystal
2(C15H14N4O),C7H6O3
CrystEngComm (2012) 14, 7 2541
a=11.1549(14)Å b=12.6194(15)Å c=13.4644(16)Å
α=113.374(2)° β=99.133(2)° γ=107.324(2)°
Trans-9,10-dihydroxy-9,10-bis(4-methoxyphenyl)-9,10-dihydroanthracene
C28H24O4
Chemical communications (Cambridge, England) (2010) 46, 10 1676-1678
a=6.2160(9)Å b=10.9301(16)Å c=16.315(2)Å
α=97.721(3)° β=90.851(3)° γ=105.319(3)°
Trans-9,10-dihydroxy-9,10-bis(4-methoxyphenyl)-9,10-dihydroanthracene
C28H24O4
Chemical communications (Cambridge, England) (2010) 46, 10 1676-1678
a=6.305(3)Å b=8.330(4)Å c=11.095(6)Å
α=95.273(8)° β=105.204(8)° γ=106.321(8)°